We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A 3D model of a human brain.

Hidden Brain Region May Unlock New Epilepsy Treatment

Cell therapy.

Cell Therapy Treatment Effectively Treats Immune-Compromised Children

A selection of diabetes monitoring and treatment neccessities.

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

Immunotherapy After Kidney Cancer Surgery Improves Overall Survival

Cannabinols Show Neuroprotective Properties in Fruit Flies

News

Symphogen’s Antibody Mixtures Highlighted in Three Peer-Reviewed Journals

Pioneering and novel approach to Anti-EGFR and Pan-HER antibodies validated in clinical and pre-clinical research papers.

Halozyme, Ventana Team Up for CDx Development

The two companies have announced an agreement to co-develop a diagnostic assay that twins with Halozyme's new investigational drug.

BioClinica and Kinapse Partner to Accelerate RBM Implementation

Bolsters adoption of compass intelligent monitoring solution.

Seeing the Action

Researchers have developed a way to observe both the forces present and the behavior that occurs during cell hemifusion; the merging of the lipid bi-layers of two cells.

Goodwin Biotechnology was Selected by Panacea Pharmaceuticals

Selected for a highly specialized vaccine fill / finish project.

Scientists are Designing Decoy Drugs to Fool Cancer

Study shows potential of drugs that can target the Notch switch with reduced toxicity.

AbbVie Completes Acquisition of Pharmacyclics

Acquisition adds Imbruvica®, one of the most promising new oncology therapies on the market, to AbbVie's portfolio.

Quintiles Launches New Solution for Emerging Asia-Pacific Companies

Emerging Companies give region strong base to transform global healthcare.

Merck Millipore Enters Into Agreement with Singulex

Acquiring exclusive worldwide rights to Singulex’s SMC™ technology - instruments, assays and services - for research applications.

Starting Antiretroviral Treatment Early Improves Outcomes for HIV-infected Individuals

NIH-funded trial results likely will impact global treatment guidelines.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter